You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 47 No. 8, August 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (40)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Positron Emission Tomographic Scanning Demonstrates a Presynaptic Dopaminergic Lesion in Lytico-Bodig

The Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex of Guam

Barry J. Snow, FRACP; Richard F. Peppard, FRACP; Mark Guttman, FRCPC; Junichi Okada, MD; W. R. Wayne Martin, FRCPC; John Steele, FRCPC; Andrew Eisen, FRCPC; Geoffrey Carr, PhD; Bruce Schoenberg, MD; Donald Calne, FRCPC

Arch Neurol. 1990;47(8):870-874.


Abstract

• We performed positron emission tomography using 18F-6-fluorodopa on four Guamanians with an amyotrophic lateral sclerosis syndrome, eight Guamanians with parkinsonism, and seven clinically normal Guamanians; the results were compared with those of nine Vancouver control subjects. The Guamanian subjects had all been exposed to similar Chamorro life-styles. The scans were analyzed using a graphic method that calculates a constant for whole striatal 18F-6-fluorodopa uptake. The parkinsonian subjects all had significantly reduced striatal 18F-6-fluorodopa uptake. The group with amyotrophic lateral sclerosis had significantly reduced uptake that was intermediate between that of the control group and the parkinsonian group. Two Guamanian normal subjects had reduced striatal 18F-6-fluorodopa uptake. The nigrostriatal dopaminergic lesion in Guamanian parkinsonism is similar to that found in idiopathic parkinsonism. The nigrostriatal lesions in the subjects with amyotrophic lateral sclerosis and the Guamanian normal subjects are examples of subclinical neuronal damage demonstrable in living subjects with positron emission tomography.



Author Affiliations

From the Belzberg Laboratory of Clinical Neurosciences, Division of Neurology, University of British Columbia, Vancouver (Drs Snow, Peppard, Guttman, Okada, Martin, Eisen, Carr, Schoenberg, and Calne); and Guam Memorial Hospital, Taumuning (Dr Steele).; Deceased.


Footnotes

Accepted for publication December 18, 1989.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neuroradiological Study of Patients With Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex on the Kii Peninsula of Japan
Kokubo and Kuzuhara
Arch Neurol 2003;60:1257-1261.
ABSTRACT | FULL TEXT  

Dopaminergic Dysfunction in Parkinsonism: New Lessons from Imaging
Marek
Neuroscientist 1999;5:333-340.
ABSTRACT  

Psychogenic Parkinsonism
Lang et al.
Arch Neurol 1995;52:802-810.
ABSTRACT  

Separating Parkinson's Disease From Normality: Discriminant Function Analysis of Fluorodopa F 18 Positron Emission Tomography Data
Sawle et al.
Arch Neurol 1994;51:237-243.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.